Terroba Chambi Cinthia, Rossi Malco, Bril Andrea, Vernetti Patricio Millar, Cerquetti Daniel, Cammarota Angel, Merello Marcelo
Movement Disorders Section Neuroscience Department Raul Carrea Institute for Neurological Research (FLENI) Buenos Aires Argentina.
Argentine National Scientific and Technological Research Council (CONICET) Buenos Aires Argentina.
Mov Disord Clin Pract. 2017 Sep 3;4(6):824-828. doi: 10.1002/mdc3.12517. eCollection 2017 Nov-Dec.
The diagnosis of Parkinson's disease (PD) can be challenging early in the disease course, when motor features are subtle. The objective of this study was to explore the diagnostic value of combining acute levodopa challenge and olfactory testing to predict PD.
Data from 210 patients with a recent onset of parkinsonism who had at least 2 years of follow-up and underwent acute levodopa challenge for the clinical prediction of long-term dopaminergic response and had olfactory testing with Sniffin' Sticks Test were evaluated. Single and combined diagnostic measures were analyzed.
After 2 years of follow-up, a PD diagnosis was confirmed in 157 patients who fulfilled United Kingdom Parkinson's Disease Society Brain Bank criteria and was ruled out in 53. Sensitivity and specificity of acute levodopa challenge to predict PD diagnosis were 0.71 and 0.94, respectively. Sensitivity and specificity of olfactory tests were calculated according to the total olfactory score for hyposmia (0.61 and 0.77 respectively), the hyposmia identification subscore (0.63 and 0.74, respectively), and the anosmia score (0.40 and 0.85, respectively). The best combination identified was response to acute levodopa challenge together with hyposmia according to the total olfactory score (sensitivity, 0.90; specificity, 0.74; positive predictive value, 0.91; negative predictive value, 0.72; accuracy, 0.86).
The combination of response to acute levodopa challenge with hyposmia according to the total olfactory score improved sensitivity for the early diagnosis of PD.
帕金森病(PD)在疾病早期,当运动特征不明显时,其诊断具有挑战性。本研究的目的是探讨联合急性左旋多巴激发试验和嗅觉测试对帕金森病的诊断价值。
对210例近期发病的帕金森综合征患者的数据进行评估,这些患者至少随访2年,接受了急性左旋多巴激发试验以预测长期多巴胺能反应,并进行了嗅觉棒测试。分析了单一和联合诊断措施。
随访2年后,157例符合英国帕金森病协会脑库标准的患者被确诊为帕金森病,53例被排除。急性左旋多巴激发试验预测帕金森病诊断的敏感性和特异性分别为0.71和0.94。嗅觉测试的敏感性和特异性根据嗅觉减退的总嗅觉评分(分别为0.61和0.77)、嗅觉减退识别子评分(分别为0.63和0.74)和嗅觉丧失评分(分别为0.40和0.85)计算。确定的最佳组合是急性左旋多巴激发试验反应与根据总嗅觉评分判断的嗅觉减退(敏感性0.90;特异性0.74;阳性预测值0.91;阴性预测值0.72;准确性0.86)。
急性左旋多巴激发试验反应与根据总嗅觉评分判断的嗅觉减退相结合,提高了帕金森病早期诊断的敏感性。